Peter Welch bought Novartis AG ADR (NYSE: NVS)
Peter Welch (D-VT), a U.S. Senator, has disclosed 2 trades in Novartis AG ADR (NVS) since 2017, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Peter Welch bought $1,001 - $15,000 of Novartis AG ADR (NYSE: NVS) on January 24, 2017. Since that trade, NVS is up +263.98% against the S&P 500 up +277.45%, an outperformance of -13.46%.
Across these filings, Peter Welch has been a balanced trader of NVS (a buy-to-sell ratio of 1.00). The most recent disclosed NVS transaction shown was dated January 25, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Peter Welch's NVS trades vs the price
NVS is up +263.98% since Peter Welch bought on January 24, 2017, versus +277.45% for the S&P 500.
Performance since this trade
All Peter Welch NVS trades
Peter Welch & NVS trading FAQ
Is it legal for Peter Welch to trade Novartis AG ADR (NVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Peter Welch buy NVS?
Peter Welch disclosed a purchase of $1,001 - $15,000 of Novartis AG ADR (NVS) on January 24, 2017, according to public STOCK Act filings.
How has NVS performed since Peter Welch's trade?
Since Peter Welch bought NVS on January 24, 2017, the stock is up +263.98%, versus +277.45% for the S&P 500 over the same period, an outperformance of -13.46%.
How many times has Peter Welch traded NVS?
Peter Welch has disclosed 2 NVS trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVS trades?
Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.
Peter Welch's NVS tradesAll congressional filings for Novartis AG ADRPeter Welch's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.